Effects of chronic morphine and morphine withdrawal on gene expression in rat peripheral blood mononuclear cells

Neuropharmacology

Volumn 55, Issue 8, 2008, Pages 1347-1354

  Desjardins, Stephane ^a   Belkai, Emilie ^a   Crete, Dominique ^a   Cordonnier, Laurie ^a   Scherrmann, Jean Michel ^a   Noble, Florence ^a   Marie Claire, Cynthia ^a  

^a CNRS   (France)

Author keywords

Dependence; Microarray analysis; Morphine; Real time quantitative RT PCR; Withdrawal

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA MICROARRAY; GENE EXPRESSION PROFILING; MALE; MORPHINE ADDICTION; NEUROMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; WITHDRAWAL SYNDROME;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LEUKOCYTES, MONONUCLEAR; MALE; MORPHINE; NARCOTICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 56249100672     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.08.027     Document Type: Article

References (47)

1. Al-Shahrour F., Minguez P., Tarraga J., Montaner D., Alloza E., Vaquerizas J.M., Conde L., Blaschke C., Vera J., and Dopazo J. Babelomics: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Res. 34 (2006) W472-W476
2. Al-Shahrour F., Minguez P., Vaquerizas J.M., Conde L., and Dopazo J. BABELOMICS: a suite of web tools for functional annotation and analysis of groups of genes in high-throughput experiments. Nucleic Acids Res. 33 (2005) W460-W464
3. Albertson D.N., Schmidt C.J., Kapatos G., and Bannon M.J. Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology 31 (2006) 2304-2312
4. Ammon S., Mayer P., Riechert U., Tischmeyer H., and Hollt V. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Brain Res. Mol. Brain Res. 112 (2003) 113-125
5. Asensio V.J., Miralles A., and Garcia-Sevilla J.A. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal. Eur. J. Pharmacol. 539 (2006) 49-56
6. Auclair A., Drouin C., Cotecchia S., Glowinski J., and Tassin J.P. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur. J. Neurosci. 20 (2004) 3073-3084
7. Beitner-Johnson D., Guitart X., and Nestler E.J. Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12 (1992) 2165-2176
8. Belcheva M.M., Haas P.D., Tan Y., Heaton V.M., and Coscia C.J. The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells. J. Pharmacol. Exp. Ther. 303 (2002) 909-918
9. Berg K.A., Zardeneta G., Hargreaves K.M., Clarke W.P., and Milam S.B. Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neuroscience 144 (2007) 889-897
10. Bidlack J.M. Detection and function of opioid receptors on cells from the immune system. Clin. Diagn. Lab. Immunol. 7 (2000) 719-723
11. Bowden N.A., Weidenhofer J., Scott R.J., Schall U., Todd J., Michie P.T., and Tooney P.A. Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr. Res. 82 (2006) 175-183
12. Du X., Tang Y., Xu H., Lit L., Walker W., Ashwood P., Gregg J.P., and Sharp F.R. Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics 87 (2006) 693-703
13. Eisenstein T.K., and Hilburger M.E. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J. Neuroimmunol. 83 (1998) 36-44
14. Fan X., Zhang J., Zhang X., Yue W., and Ma L. Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain. Neuropharmacology 43 (2002) 809-816
15. Ferrer-Alcon M., Garcia-Sevilla J.A., Jaquet P.E., La Harpe R., Riederer B.M., Walzer C., and Guimon J. Regulation of nonphosphorylated and phosphorylated forms of neurofilament proteins in the prefrontal cortex of human opioid addicts. J. Neurosci. Res. 61 (2000) 338-349
16. Ferrer-Alcon M., La Harpe R., and Garcia-Sevilla J.A. Decreased immunodensities of [mu]-opioid receptors, receptor kinases GRK 2/6 and [beta]-arrestin-2 in postmortem brains of opiate addicts. Mol. Brain Res. 121 (2004) 114-122
17. Garcia-Sevilla J.A., Ventayol P., Perez V., Rubovszky G., Puigdemont D., Ferrer-Alcon M., Andreoli A., Guimon J., and Alvarez E. Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment. Neuropsychopharmacology 29 (2004) 580-588
18. Gaveriaux-Ruff C., Matthes H.W., Peluso J., and Kieffer B.L. Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6326-6330
19. Gaveriaux C., Peluso J., Simonin F., Laforet J., and Kieffer B. Identification of kappa- and delta-opioid receptor transcripts in immune cells. FEBS Lett. 369 (1995) 272-276
20. Gold S.J., Han M.H., Herman A.E., Ni Y.G., Pudiak C.M., Aghajanian G.K., Liu R.J., Potts B.W., Mumby S.M., and Nestler E.J. Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur. J. Neurosci. 17 (2003) 971-980
21. Hershey A.D., Tang Y., Powers S.W., Kabbouche M.A., Gilbert D.L., Glauser T.A., and Sharp F.R. Genomic abnormalities in patients with migraine and chronic migraine: preliminary blood gene expression suggests platelet abnormalities. Headache 44 (2004) 994-1004
22. Hilburger M.E., Adler M.W., Rogers T.J., and Eisenstein T.K. Morphine alters macrophage and lymphocyte populations in the spleen and peritoneal cavity. J. Neuroimmunol. 80 (1997) 106-114
23. Iga J., Ueno S., and Ohmori T. Molecular assessment of depression from mRNAs in the peripheral leukocytes. Ann. Med. 40 (2008) 336-342
24. Kim K.S., Lee K.W., Lee K.W., Im J.Y., Yoo J.Y., Kim S.W., Lee J.K., Nestler E.J., and Han P.L. Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 3908-3913
25. Li C., and Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 31-36
26. Marek G.J. Behavioral evidence for mu-opioid and 5-HT2A receptor interactions. Eur. J. Pharmacol. 474 (2003) 77-83
27. Marie-Claire C., Courtin C., Roques B.P., and Noble F. Cytoskeletal genes regulation by chronic morphine treatment in rat striatum. Neuropsychopharmacology 29 (2004) 2208-2215
28. McCarthy L., Wetzel M., Sliker J.K., Eisenstein T.K., and Rogers T.J. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 62 (2001) 111-123
29. McClung C.A., Nestler E.J., and Zachariou V. Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J. Neurosci. 25 (2005) 6005-6015
30. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2 (2001) 119-128
31. Pacifici R., di Carlo S., Bacosi A., Pichini S., and Zuccaro P. Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int. J. Immunopharmacol. 22 (2000) 603-614
32. Peterson P.K., Gekker G., Brummitt C., Pentel P., Bullock M., Simpson M., Hitt J., and Sharp B. Suppression of human peripheral blood mononuclear cell function by methadone and morphine. J. Infect. Dis. 159 (1989) 480-487
33. Rahim R.T., Adler M.W., Meissler Jr. J.J., Cowan A., Rogers T.J., Geller E.B., and Eisenstein T.K. Abrupt or precipitated withdrawal from morphine induces immunosuppression. J. Neuroimmunol. 127 (2002) 88-95
34. Roy S., Wang J., Gupta S., Charboneau R., Loh H.H., and Barke R.A. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. J. Neuroimmunol. 147 (2004) 78-81
35. Schulz R., Eisinger D.A., and Wehmeyer A. Opioid control of MAP kinase cascade. Eur. J. Pharmacol. 500 (2004) 487-497
36. Sharp B.M. Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav. Immun. 20 (2006) 9-14
37. Sharp B.M., Roy S., and Bidlack J.M. Evidence for opioid receptors on cells involved in host defense and the immune system. J. Neuroimmunol. 83 (1998) 45-56
38. Stefano G.B., Burrill J.D., Labur S., Blake J., and Cadet P. Regulation of various genes in human leukocytes acutely exposed to morphine: expression microarray analysis. Med. Sci. Monit. 11 (2005) MS35-MS42
39. Sullivan P.F., Fan C., and Perou C.M. Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141 (2006) 261-268
40. Suzuki S., Chuang L.F., Doi R.H., Bidlack J.M., and Chuang R.Y. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence. Int. J. Immunopharmacol. 1 (2001) 1733-1742
41. Suzuki S., Chuang T.K., Chuang L.F., Doi R.H., and Chuang R.Y. Morphine upregulates kappa-opioid receptors of human lymphocytes. Adv. Exp. Med. Biol. 493 (2001) 81-87
42. Suzuki S., Miyagi T., Chuang T.K., Chuang L.F., Doi R.H., and Chuang R.Y. Morphine upregulates mu opioid receptors of human and monkey lymphocytes. Biochem. Biophys. Res. Commun. 279 (2000) 621-628
43. Tang Y., Gilbert D.L., Glauser T.A., Hershey A.D., and Sharp F.R. Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch. Neurol. 62 (2005) 210-215
44. Tang Y., Schapiro M.B., Franz D.N., Patterson B.J., Hickey F.J., Schorry E.K., Hopkin R.J., Wylie M., Narayan T., Glauser T.A., Gilbert D.L., Hershey A.D., and Sharp F.R. Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome. Ann. Neurol. 56 (2004) 808-814
45. Traynor J.R., and Neubig R.R. Regulators of G protein signaling and drugs of abuse. Mol. Interv. 5 (2005) 30-41
46. Uings I.J., and Farrow S.N. Cell receptors and cell signalling. J. Clin. Pathol. 53 (2000) 295-299
47. Wick M.J., Minnerath S.R., Roy S., Ramakrishnan S., and Loh H.H. Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes. J. Neuroimmunol. 64 (1996) 29-36